New treatments give cancer patients a longer life
Researchers said that the new treatments are making much progress to help cancer patients survive longer.
Researchers try and ways to combine the best of the best methods of treatment-oriented and other types of old drugs to earn a few months or even years for the cancer patient.
Thanks to these new therapies, the rate of survival of patients with all types of cancer combined five years and included 63 per cent of cancer patients, according to figures from the American Cancer Society, compared with 51% in 1975.
For example, the use of the drug Erbitux with radiation therapy has helped patients with head and neck cancer to survive longer without the cancer spreads in their bodies.
In patients given Avastin and Tarceva real estate lived 71% of patients cured hopeless type of kidney cancer six months or more than they expect their doctors.
Some drugs effective against impact when used with appropriate cases. It achieves good results with only 10% of patients, the researchers hope to increase this percentage when using new treatments.
Cancer is the second most disease leads to death in the United States after heart disease. It is expected to be infected this year, 1.368 million American cancer and 563,700 die with the disease.
Researchers said that the new treatments are making much progress to help cancer patients survive longer.
Researchers try and ways to combine the best of the best methods of treatment-oriented and other types of old drugs to earn a few months or even years for the cancer patient.
Thanks to these new therapies, the rate of survival of patients with all types of cancer combined five years and included 63 per cent of cancer patients, according to figures from the American Cancer Society, compared with 51% in 1975.
For example, the use of the drug Erbitux with radiation therapy has helped patients with head and neck cancer to survive longer without the cancer spreads in their bodies.
In patients given Avastin and Tarceva real estate lived 71% of patients cured hopeless type of kidney cancer six months or more than they expect their doctors.
Some drugs effective against impact when used with appropriate cases. It achieves good results with only 10% of patients, the researchers hope to increase this percentage when using new treatments.
Cancer is the second most disease leads to death in the United States after heart disease. It is expected to be infected this year, 1.368 million American cancer and 563,700 die with the disease.
